A high-purity chitinase protein crystal and its preparation method and application

By expressing and purifying soybean cyst nematode chitinase and analyzing its crystal structure, the problem of lack of effective prevention and treatment methods is solved, providing a basis for pesticide design and screening out inhibitors, achieving effective prevention and control of cyst nematodes.

CN117106757BActive Publication Date: 2024-11-01INST OF PLANT PROTECTION CHINESE ACAD OF AGRI SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311194972.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-09-15
Publication Date
2024-11-01
Estimated Expiration
2043-09-15

AI Technical Summary

Technical Problem

Currently, there is a lack of effective methods to prevent and treat soybean cyst nematodes, and no relevant reports have been reported on the three-dimensional structure of chitinase of cyst nematodes, which hinders the pesticide design for this pest.

Method used

By constructing chitinase expression vector, recombinant expression and purification, high-purity soybean cyst nematode chitinase protein crystals were obtained, and crystallization conditions were screened through the suspended air phase diffusion method, their crystal structure was analyzed, and further connected through molecular docking. Software screening inhibitors.

Benefits of technology

The high-purity chitinase protein crystal was successfully obtained, and its three-dimensional structure was analyzed, providing a basis for the design of targeted pesticides, and screening out candidate nematodetics with inhibitory effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure SMS_4
    Figure SMS_4
Patent Text Reader

Abstract

The present invention relates to a high-purity chitinase protein crystal and a preparation method and application thereof. The present invention successfully expresses and purifies a high-purity cyst nematode chitinase protein by genetic engineering, and simultaneously screens out the crystallization conditions under which the protein can form a perfect crystal form. Finally, crystal data is collected by X-ray crystal diffraction, and the crystal structure of the protein is analyzed. Drugs can be designed based on the protein structure and related molecular action mechanism research can be carried out.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to a high-purity chitinase protein crystal structure and a crystal preparation method and an analysis method. Background Art

[0002] Cyst nematodes are widely distributed throughout the world and are a type of pest that can cause serious yield losses in many important crops. Taking the most serious soybean cyst nematode (Soybean Cyst Nematode, Heteroderaglycines, SCN) as an example, it is one of the main pests on soybeans and can cause damage throughout the entire growth period of soybeans, generally causing 5-10% yield losses. The yield reduction in severely affected plots can reach more than 30%, or even no grain is harvested, resulting in serious yield reduction and causing large economic losses. In addition to the harm to soybeans, soybean cyst nematodes can also affect the establishment of rhizobium nodulation symbiosis, resulting in a weakening of the nitrogen fixation ability of the nodules, further leading to soybean yield reduction. However, there is currently no effective prevention and control method for cyst nematodes, so it is urgent to develop new methods for preventing and controlling cyst nematodes.

[0003] Studies have shown that chitin is a component of cyst nematode eggs, located between the outer yolk layer and the inner lipid layer, and mainly has the function of preventing polyspermia from entering the eggs and blocking the external environment, which is crucial for the further development of the embryo. In addition to the egg shell, the pharynx and feeding parts of the cyst nematode also contain chitin, which plays an important role in the parasitic process (Chen, Q. et al., Nematode chitin and application. Adv. Exp. Med. Biol. 2019, 1142: 209-219). Therefore, the cyst nematode chitinase is also an ideal potential target for the prevention and treatment of soybean cyst nematode disease. In addition, the cyst nematode secretes a lot of effector proteins from being attracted to the root tip to forming syncytium to help it complete the infection and colonization process. Among them, the soybean cyst nematode chitinase HgCht2 (also known as Hg-CHI-1) is an effector protein highly expressed in the early stage of infection, has nodulation factor hydrolysis activity, and plays an important role in the inhibition of rhizobium symbiosis by soybean cyst nematodes. Therefore, cyst nematode chitinase is also an ideal target for legume symbiotic protectants.

[0004] In summary, cyst nematode chitinase has important application prospects in the agricultural field, and obtaining the three-dimensional structure of cyst nematode chitinase plays a very important role in understanding its biological functions and designing targeted pesticides. Therefore, obtaining the functional domain crystal of cyst nematode chitinase and analyzing its three-dimensional structure are worthy of in-depth research, but there are no related reports at home and abroad. Summary of the invention

[0005] In view of the needs of the prior art, the present invention provides a purification method for purifying chitinase from cyst nematodes through the exploration of purification processes. The method is used to obtain highly pure chitinase from soybean cyst nematodes, prepare its protein crystals and analyze the crystal structure.

[0006] The technical solution of the present invention to solve the above technical problems is as follows:

[0007] The present invention provides a soybean cyst nematode chitinase protein crystal, which has a space group P1211, one molecule in an asymmetric unit, and a unit cell parameter of

[0008] The expression and purification method of the chitinase protein comprises the following steps:

[0009] (1) Construction of chitinase expression vector

[0010] Connect the target gene to the vector to obtain a recombinant plasmid, then transform the recombinant plasmid into competent cells for culture, pick a single clone colony for amplification and sequencing;

[0011] The specific operation of step (1) is to optimize the codons of the target gene for Pichia pastoris preference, perform gene synthesis, and clone the synthesized gene into the pPIC9 vector.

[0012] (2) Recombinant expression of chitinase

[0013] The correctly sequenced chitinase recombinant vector is transformed into a host cell to obtain a strain expressing chitinase. The expression strain is inoculated into a culture medium for cultivation, and the culture medium supernatant is collected by centrifugation;

[0014] The specific operation of step (2) is to transform the constructed pPIC9 plasmid containing chitinase into Pichia pastoris GS115 competent cells by the click method. Cultivate at 30°C on a shaker for 2 hours. Then spread the bacterial solution on a histidine-deficient solid plate and culture at 30°C for 48 hours until a single colony of suitable size is observed. All the observed single colonies are picked out and dissolved in 50 μL sterile water. After repeated freezing and thawing 3 times with boiling water and liquid nitrogen, the supernatant is collected by centrifugation and used as a template for PCR fragment amplification to determine the positive single colony. The selected positive monoclonal clone is activated using YPD liquid culture medium until the OD value is 1.3-1.5, and then inoculated into BMGY liquid culture medium at a ratio of 1:100, and cultured overnight at 30°C on a shaker at 200 rpm until the OD value is 2.0. Then the bacteria are collected by centrifugation at room temperature, and the centrifugation condition is 3000g. Then the bacteria are transferred to BMMY liquid culture medium and cultured for 5 days under the same culture conditions, during which 1% (v / v) methanol is added every day. The mixture was then centrifuged at 8000 g for 30 min at room temperature and the supernatant was collected.

[0015] (3) Purification of chitinase

[0016] The culture medium supernatant containing chitinase is loaded onto a column or gel capable of binding to a His affinity tag, such as a HisTrap HP affinity chromatography column, and the column is first equilibrated with a buffer solution at pH 7.0-8.0, and then impurities are washed with a buffer solution at pH 7.0-8.0 containing a low concentration of imidazole, and finally the target protein is eluted with a buffer solution at pH 7.0-8.0 containing a high concentration of imidazole; the chitinase contains a His tag, and preferably the His tag is a 6*His tag.

[0017] The specific operation of step (3) is to slowly add 500g / L ammonium sulfate to the supernatant of the fermentation broth at 4°C. To prevent the local salt concentration from being too high, the whole process needs to be stirred continuously. After the ammonium sulfate is completely dissolved, it is left to stand overnight. The precipitate is collected by centrifugation at 4°C, and then dissolved with buffer A at 4°C, and centrifuged again at 4°C to remove undissolved impurities. The supernatant is filtered through a 0.22μm pore size filter to remove fine impurities again, and then a desalting pre-loaded column is used to remove salt from the sample. The desalted sample is loaded into a HisTrap HP affinity chromatography column that has been equilibrated with buffer A, and then equilibrated again with 20 column volumes of buffer A, and then washed with 96% buffer A+4% buffer B and 90% buffer A+10% buffer B to remove impurities, and the target protein is eluted with 60% buffer A+40% buffer B. Finally, the obtained protein is analyzed for purity using SDS-PAGE.

[0018] The buffer A consists of 20 mM sodium phosphate, 0.5 M NaCl, pH 7.4; the buffer B consists of 20 mM sodium phosphate, 0.5 M NaCl, 500 mM imidazole, pH 7.4.

[0019] The chitinase is derived from cyst nematodes, preferably the chitinase is a chitinase from cyst nematodes having an amino acid sequence identity of more than 90%, more than 95%, 98% and more preferably more than 99% with HgCht2 of soybean cyst nematodes, more preferably, the chitinase is HgCht2 derived from soybean cyst nematodes.

[0020] The chitinase protein crystals are prepared by the following method:

[0021] (1) desalting and concentrating the purified chitinase;

[0022] The specific operation of step (1) is to desalt the HgCht2 separated and purified by nickel ion affinity chromatography into 20mM Tris-HCl buffer (pH 7.0, 100mM NaCl), and then concentrate it to 15mg / mL by centrifugation.

[0023] (2) Using the hanging drop vapor diffusion method to screen the crystallization conditions of chitinase and obtain chitinase protein crystals;

[0024] The specific operation of step (2) is to use the hanging drop vapor diffusion method to perform preliminary screening of crystallization conditions. The crystallization screening conditions used are Index, Crystal Screen, Crystal Screen 2 (Hampton Research) and The JCSG Core Suites I-IV kit (Qiagen) of commercial sources. The above-mentioned crystallization kit screening solution is added as a pool liquid into a 24-well crystal culture plate, and 1 μL of concentrated protein is mixed with 1 μL of crystal pool liquid on a silicon wafer, then inverted into the crystal culture plate and sealed. The culture plate is placed in a 4°C constant temperature incubator, and the crystal growth on the silicon wafer is observed regularly. The final screened HgCht2 crystal growth conditions are 0.1M ammonium acetate, 0.1M Bis-tris, pH 5.5, and 20% PEG 10,000.

[0025] (3) Transfer the chitinase protein crystals into antifreeze solution and store them in liquid nitrogen

[0026] The specific operation of step (3) is to soak the grown protein crystals in an antifreeze protection solution for 5 seconds, wherein the antifreeze solution is a solution containing 20-25% glycerol as a cryoprotectant under crystal growth conditions, and then transfer the crystals to liquid nitrogen for storage.

[0027] The present invention also provides the use of the soybean cyst nematode chitinase protein crystal in screening inhibitors with chitinase inhibitory effects or candidate nematicides for preventing and controlling cyst nematodes.

[0028] Further provided is a method for screening inhibitors having an inhibitory effect on chitinase or candidate nematicides for controlling cyst nematodes, comprising the following steps: using molecular docking software such as Autodockvina to virtually screen candidate compounds for shape and / or electrical similarity;

[0029] Further including molecular docking screening;

[0030] Optionally, an assessment of inhibitory activity is also performed.

[0031] The shape similarity screening is specifically as follows: using the substrate of HgCht2, such as chitosan oligosaccharide, as a template, generating the three-dimensional structure of the compound through the Omega program, and using the ROCS program to calculate the molecular shape similarity between the compound structure in the database and the template;

[0032] The electrical similarity screening specifically includes: using the EON program to calculate the charge similarity of the candidate compounds based on the MMFF force field, and scoring the compounds with the ET_Combo score.

[0033] Preferably, the molecular docking screening is to use Glide software to target HgCht2 crystals, perform molecular docking on candidate compounds, observe docking results, and determine the interaction between small molecules and conserved motifs;

[0034] In addition, preferably, the selected compound library is subjected to shape virtual screening, compounds with high scores are selected, and then they are subjected to electrical similarity virtual screening, and compounds with high scores are further selected, and then molecular docking screening is performed.

[0035] The present invention has the following beneficial effects:

[0036] The present invention successfully expressed and purified the cyst nematode chitinase protein with high purity through genetic engineering methods, and screened out the crystallization conditions under which the protein can form a perfect crystal form. Finally, crystal data was collected through X-ray crystal diffraction and the crystal structure of the protein was analyzed, providing a basis for future drug design based on the protein structure and related molecular action mechanisms. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] Figure 1 This is the detection diagram of high-purity HgCht2 protein.

[0038] Figure 2 This is the crystal structure diagram of HgCht2. DETAILED DESCRIPTION

[0039] The present invention will be further described below in conjunction with specific embodiments, and the advantages and features of the present invention will become clearer as the description proceeds. However, it should be understood that the embodiments are exemplary only and do not constitute any limitation to the scope of the present invention. It should be understood by those skilled in the art that the details and forms of the technical solution of the present invention may be modified or replaced without departing from the spirit and scope of the present invention, but these modifications or replacements all fall within the protection scope of the present invention.

[0040] The reagents and biological materials used in the examples are all commercially available.

[0041] The amino acid sequence of chitinase HgCht2 of soybean pathogenic microorganism soybean cyst nematode selected in the present invention is shown as SEQ ID No.1.

[0042] Example 1: Preparation method of high-purity soybean cyst nematode chitinase HgCht2

[0043] 1. Expression of HgCht2 recombinant protein

[0044] 1) Synthesis of target gene

[0045] Codon optimization was performed according to the gene sequence of HgCht2 protein (protein accession number AAN14978.1, mRNA accession number AF468679.1), and then the whole gene cDNA was synthesized; a 6*His tag and a stop codon were added to the C-terminus.

[0046] 2) Construction of expression vector

[0047] The restriction endonuclease sites of HgCht2 were analyzed, and the plasmid was linearized using the restriction endonuclease Pme I. The linearized plasmid was recovered by a DNA fragment recovery kit. Pichia pastoris GS115 competent cells were prepared, and the plasmid and competent cells were co-incubated on ice for 5 minutes before electroporation transformation. The electroporation conditions were 1.5 kV and 4.8-5.5 ms. 300 μL of 4°C sorbitol solution was added to the electroporated cells, and then the solution was transferred to a 2 mL centrifuge tube and cultured on a 30°C shaker for 2 hours. The bacterial solution was then spread on a histidine-deficient solid plate and statically cultured at 30°C for 48 hours until a single colony of the appropriate size was observed. All the observed single colonies were picked out and dissolved in 50 μL sterile water. After repeated freezing and thawing 3 times with boiling water and liquid nitrogen, the supernatant was collected by centrifugation and used as a template for PCR fragment amplification to determine the positive single colony for subsequent recombinant expression.

[0048] 3) Inducible expression of proteins

[0049] The selected positive monoclones were activated using YPD liquid medium until the OD value was 1.3-1.5, and then inoculated into BMGY liquid medium at a ratio of 1:100, and cultured overnight at 30°C shaker 200rpm until the OD value was 2.0. The cells were then collected by centrifugation at room temperature at 3000g. The cells were then transferred to BMMY liquid medium and cultured under the same culture conditions for 5 days, during which 1% (v / v) methanol was added every day. The supernatant was then collected by centrifugation at 8000g for 30 minutes at room temperature.

[0050] 2. Isolation and purification of HgCht2 recombinant protein

[0051] 500 g / L of ammonium sulfate was slowly added to the fermentation broth supernatant at 4 ° C. To prevent the local salt concentration from being too high, the whole process required continuous stirring, and the ammonium sulfate was completely dissolved and then left to stand overnight. The precipitate was collected by centrifugation at 4 ° C, and then dissolved with Buffer A at 4 ° C, and then centrifuged again at 4 degrees Celsius to remove undissolved impurities. The supernatant was filtered through a 0.22 μm pore size filter to remove fine impurities again, and then a desalting pre-packed column (GE healthcare) was used to remove salt from the sample. The desalted sample was loaded into a HisTrap HP affinity chromatography column (GE healthcare) that had been equilibrated with Buffer A, and then equilibrated again with 20 column volumes of Buffer A, and then washed with 96% Buffer A + 4% Buffer B and 90% Buffer A + 10% Buffer B to remove impurities, and the target protein was eluted with 60% Buffer A + 40% Buffer B. Finally, the obtained protein was analyzed for purity using SDS-PAGE.

[0052] Buffer A consists of 20 mM sodium phosphate, 0.5 M NaCl, pH 7.4; Buffer B consists of 20 mM sodium phosphate, 0.5 M NaCl, 500 mM imidazole, pH 7.4.

[0053] The results showed that high-purity HgCht2 protein was obtained through purification (see Figure 1 ), which can be used for protein crystal preparation.

[0054] Example 2: Preparation and preservation of soybean cyst nematode chitinase HgCht2 protein crystals

[0055] 1. Preparation of HgCht2 protein crystals

[0056] After being separated and purified by nickel ion affinity chromatography, HgCht2 was desalted to 20mMTris-HCl buffer (pH7.0, 100mMNaCl) and concentrated to 15mg / mL by centrifugation. The hanging drop vapor diffusion method was used for preliminary screening of crystallization conditions. The crystallization screening conditions used were commercially available Index, Crystal Screen, Crystal Screen 2 (HamptonResearch) and The JCSG Core Suites I-IV kit (Qiagen). The screening solution of the above crystallization kit was added as a pool solution to a 24-well crystal culture plate. On the silicon wafer, 1μL of concentrated protein was mixed with 1μL of crystal pool solution and then inverted in the crystal culture plate and sealed. The culture plate was placed in a 4℃ constant temperature incubator and the crystal growth on the silicon wafer was observed regularly. The final screening HgCht2 crystal growth conditions were 0.1M ammonium acetate, 0.1M Bis-tris, pH 5.5, and 20% PEG10000. .

[0057] 2. Preservation of HgCht2 protein crystals

[0058] The grown protein crystals were immersed in an antifreeze protection solution for 5 seconds. The antifreeze solution was a crystal growth condition supplemented with 20-25% glycerol as a cryoprotectant, and then transferred to liquid nitrogen for storage.

[0059] Example 3: Crystal structure analysis of soybean cyst nematode chitinase HgCht2 protein

[0060] The protein crystals stored in liquid nitrogen were transported to the Shanghai Synchrotron Radiation Center, and data were collected through the BL18U beamline. One diffraction spectrum was collected every time the crystal rotated 1°, and a total of 360 diffraction patterns were collected. The diffraction data were integrated using the HKL-3000 package. Using the chitinase CeCht1 (PDB entry 6LDU) of C. elegans as a model, the structure of HgCht2 was solved by molecular replacement using Phaser. The structure of molecular replacement was corrected using PHENIX software, the molecular model was manually built and expanded using the Coot program, and the three-dimensional structure of the model was confirmed using PROCHECK. All atomic coordinates and structure factors were submitted to the Protein Data Bank (http: / / wwwpdb.org) with the accession number 8HW6. The crystal has a space group P1211, one molecule in an asymmetric unit, and the unit cell parameters are (See Table 1 for details) (Results Figure 2 ).

[0061] Table 1 Crystallographic data collection and structure correction data statistics

[0062]

[0063]

[0064] The data in brackets are the high-resolution results. work and R free Defined as R = Σ hkl ||F obs |-|F calc || / Σ hkl |F obs |, where h, k, and l refer to the reflectance index (for R work Refinement; 5%, not used for R free Fine), F obs and F calc is the structure factor, inferred from the measured intensities and obtained by model calculations.

[0065] Example 4: Method for screening inhibitors based on the crystal structure of chitinase

[0066] Structure-based screening and design have become an important approach to inhibitor development. Therefore, the crystal structure of cyst nematode chitinase is crucial for further screening based on structural information to obtain highly effective inhibitors, and is the core foundation and important basis for the development of new target-based pesticides. The specific screening method steps are as follows:

[0067] (1) Select a compound library containing different molecules, such as the ZINC database containing about 4 million commercial compounds, as a virtual screening compound library, and use molecular docking software such as Autodockvina to perform virtual screening of the compounds in the ZINC database based on shape and electrical similarity:

[0068] ① Shape similarity screening: Using the substrate of HgCht2, such as chitosan oligosaccharide, as a template, the three-dimensional structure of the compound is generated by the Omega program, and the molecular shape similarity between the compound structure in the database and the template is calculated using the ROCS program. The compounds are ranked by Tanimoto Combo scores to determine the 1000 compounds with the highest scores.

[0069] ②Electrical similarity screening: Use the EON program to perform charge similarity calculations based on the MMFF force field on the 1000 compounds with the highest TanimotoCombo scores, rank the compounds by ET_Combo scores, and select the 500 compounds with the highest scores as ligands for subsequent molecular docking.

[0070] (2) Molecular docking: Using Glide software, molecular docking was performed on 500 compounds with the crystal structure of HgCht2 as the target, and the 10 compounds with the highest scores were selected to evaluate the inhibitory activity. The specific method for determining the inhibitory activity is as follows:

[0071] Positive control: 3 sets of parallel positive controls were set up. Under the conditions of 30℃ reaction temperature, 100μL reaction system, 2nmol / L chitinase and 50μmol / L substrate (MU-(GlcNAc) 2 ) was incubated in 20 mmol / L pH 6.0 phosphate buffer for 30 min, and then 100 μL 0.5 mol / L sodium carbonate solution was added to terminate the reaction. The reaction solution was excited with 360 nm wavelength excitation light and the absorbance value at 450 nm wavelength was measured.

[0072] Experimental group: 3 parallel experimental groups were set up. Under the conditions of 30℃ reaction temperature, 100μL reaction system, 2nmol / L chitinase and 50μmol / L substrate (MU-(GlcNAc) 2 ) and 100 μM of the selected compound were incubated in 20 mmol / L pH 6.0 phosphate buffer for 30 min, then 100 μL 0.5 mol / L sodium carbonate solution was added to terminate the reaction, and the reaction solution was excited with 360 nm wavelength excitation light and the absorbance value at 450 nm wavelength was measured. The inhibitory activity was calculated according to the following formula: Inhibition percentage = (positive control - experimental group) / positive control * 100. Table 2 is an example of the inhibitory activity data of up to 500 compounds screened by the above method, which are known compounds, which further verifies that the screening method of the present invention is feasible.

[0073] Table 2 Inhibitory activity of high-scoring compounds against HgCht2

[0074]

[0075] Therefore, the inhibitor having an inhibitory effect on chitinase can be obtained by the above method, and can also be used as a candidate nematicide for controlling cyst nematodes.

Claims

1. A soybean cyst nematode chitinase protein crystal, the crystal having a space group P1211, one molecule in one asymmetric unit, and unit cell parameters of a=46.80Å, b=69.35Å, c=50.56Å; the chitinase protein is HgCht2 of soybean cyst nematode, and the NCBI accession number of its amino acid sequence is AAN14978.

1.

2. The method for preparing chitinase protein crystals according to claim 1, characterized in that: The purified chitinase protein is obtained by growing crystals under the conditions of 0.1 M ammonium acetate, 0.1 M Bis-tris, pH 5.5 and 20% PEG 10,000; wherein the crystal growth is carried out by a hanging drop vapor diffusion method.

3. The method for preparing chitinase protein crystals according to claim 2, characterized in that: The chitinase protein crystals are transferred into an antifreeze solution and stored in liquid nitrogen; and the antifreeze solution is supplemented with 20-25% glycerol as a cryoprotectant under crystal growth conditions.

4. The method for preparing chitinase protein crystals according to claim 2, characterized in that: The purified chitinase protein is separated and purified by nickel ion affinity chromatography, desalted to 20 mM Tris-HCl buffer (pH 7.0, 100 mM NaCl), and then concentrated to 15 mg / mL by centrifugation.

5. The method for preparing chitinase protein crystals according to claim 4, characterized in that: The purified chitinase protein is prepared according to the following method: obtaining the culture fluid containing the chitinase protein by expressing the encoding gene of the chitinase protein with a His affinity tag through a recombinant expression host bacterium, collecting the supernatant by centrifugation; loading the supernatant onto a column or gel capable of binding to the His affinity tag, first balancing the column with a buffer solution of pH 7.0-8.0, then washing impurities with a buffer solution of pH 7.0-8.0 containing a low concentration of imidazole, and finally eluting the target protein with a buffer solution of pH 7.0-8.0 containing a high concentration of imidazole.

6. The method for preparing chitinase protein crystals according to claim 4, characterized in that: The specific operation of the purification and desalting is: slowly add 500 g / L ammonium sulfate to the supernatant of the fermentation broth at 4°C, stir continuously during the whole process, and stand overnight after the ammonium sulfate is completely dissolved; collect the precipitate by centrifugation at 4°C, then dissolve it with buffer A at 4°C, and centrifuge it again at 4°C to remove the undissolved impurities; pass the supernatant through a 0.22 μm pore size filter to remove fine impurities again; load the desalted sample into a HisTrap HP affinity chromatography column that has been equilibrated with buffer A, and then equilibrate it again with 20 column volumes of buffer A, and then use 96% buffer A+4% buffer B and 90% buffer A+10% buffer B to wash away the impurities, and use 60% buffer A+40% buffer B to elute the target protein; The buffer A consists of 20 mM sodium phosphate, 0.5 M NaCl, pH 7.4; the buffer B consists of 20 mM sodium phosphate, 0.5 M NaCl, 500 mM imidazole, pH 7.

4.

7. Use of the soybean cyst nematode chitinase protein crystal according to claim 1 in screening inhibitors having an inhibitory effect on chitinase or candidate nematicides for controlling cyst nematodes.

8. A method for screening a chitinase inhibitor or a candidate nematicide for controlling cyst nematodes, comprising the following steps: using molecular docking software such as Autodockvina to virtually screen candidate compounds for shape and / or electrical similarity; Further includes molecular docking screening.

9. The method according to claim 8, characterized in that Evaluation of inhibitory activity is also included.

10. The method according to claim 8, characterized in that The shape similarity screening is specifically as follows: using the substrate of HgCht2, such as chitosan oligosaccharide, as a template, generating the three-dimensional structure of the compound through the Omega program, and using the ROCS program to calculate the molecular shape similarity between the compound structure in the database and the template; The electrical similarity screening specifically includes: using the EON program to calculate the charge similarity of the candidate compounds based on the MMFF force field, and scoring the compounds with the ET_Combo score.

11. The method according to claim 8, characterized in that The molecular docking screening is to use Glide software to target HgCht2 crystals, perform molecular docking on candidate compounds, observe docking results, and determine the interaction between small molecules and conserved motifs.

12. The method according to claim 10, characterized in that The selected compound library is subjected to shape virtual screening to select compounds with high scores, which are then subjected to virtual screening of electrical similarity to further select compounds with high scores for molecular docking screening.